'The present study illustrates great potentials of chimeric antigen receptor (CAR-T) cells targeting B cell maturation antigen in treating anti-signal recognition particle myopathy, with sustained depletion of autoantibodies and therapeutic efficacies beyond 18 mo.'
#immunotherapy #CARTcells

https://www.pnas.org/doi/10.1073/pnas.2315990121